R-Biopharm AG
Petra Krinn is a seasoned professional in quality assurance and post-market surveillance within the biotechnology and food industries. Currently serving as a Post-Market Surveillance & Vigilance Specialist at R-Biopharm AG since May 2013, Petra is responsible for the implementation of post-market surveillance and vigilance according to IVDR regulations. Previous roles include Project Manager and Documentation Coordinator at R-Biopharm AG, and Quality Assurance Specialist at Progen Biotechnik GmbH, where responsibilities encompassed ISO compliance, risk management, and internal audits. Earlier experience includes positions in quality assurance and technical roles at companies such as Sunval Nahrungsmittel GmbH and Becton Dickinson GmbH, alongside academic foundations in dairy and quality management, underscoring a robust proficiency in regulatory adherence and quality improvement initiatives.
This person is not in any offices
R-Biopharm AG
R-Biopharm AG, located in Darmstadt, is one of Germany’s leading biotechnology companies. It considers itself as a pioneer for health and quality of life. The company´s aspiration is to provide the highest possible precision, safety, clarity and certainty with excellent products and solutions – in prevention, therapy and healing. Research and development at R-Biopharm has developed agile processes in order to take on new challenges to accompany a steadily growing world population into a new health era with sustainable solutions. As an internationally recognized leader, R-Biopharm stands for the development of excellent technologies, products and solutions in the fields of Clinical Diagnostics, Nutrition Care and Food and Feed Analytics. R-Biopharm is the global market leader for test systems in the field of allergen analysis. The biotechnology company is known for its products that are of high importance for human health. To this end, it unites development, production and sales under one roof and is successfully represented in more than 120 countries worldwide – through 28 subsidiaries and 120 distributors. Founded in 1988, the family-run company employs a total of around 1,300 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the “Sustainability Award” for sustainable and profitable growth. R-Biopharm is cultivating a value-oriented corporate culture and management and is family-run in the second generation. The Chairman of the Board of Directors is Christian Dreher.